Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/(SICI)1520-6661(199801/02)7:1<8::AID-MFM2>3.0.CO;2-S 3.0.CO;2-S target="_blank">http://scihub22266oqcxt.onion/10.1002/(SICI)1520-6661(199801/02)7:1<8::AID-MFM2>3.0.CO;2-S 9502662!ä!9502662 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Matern+Fetal+Med 1998 ; 7 (1): 8-12 Nephropedia Template TP {{tp|p=9502662|t=1998. Preterm premature rupture of membranes: aggressive tocolysis versus expectant management |pdf=|usr=}}{{9502662}} gab.com Text Preterm premature rupture of membranes: aggressive tocolysis versus expectant management JO: J Matern Fetal Med http://www.kidney.de/pget.php?&tw=1&pmid=9502662 #FOAvip The objective of our study is to determine whether aggressive tocolysis in patients with preterm premature rupture of membranes between 24 and 34 weeks gestation improves neonatal outcome. Patients with documented preterm premature rupture of membranes between 24 and 34 weeks gestation were prospectively randomized to group I, aggressive tocolysis with intravenous magnesium sulfate, or to group II, no tocolysis. The lecithin/sphingomyelin ratio was determined upon hospital admission and every 48-96 hours until delivery. Both groups received weekly steroids and antibiotics pending culture results and were promptly delivered when chorioamnionitis, fetal stress, or an Lecithin/sphingomyelin ratio of > or = 2.0 occurred. The study group involved 145 patients. No statistically significant differences between groups I (n = 78) and II (n = 67) were observed regarding demographic characteristics, gestational age at enrollment or at delivery, latency, development of clinical chorioamnionitis, birth weight, number of days in neonatal intensive care unit, days on oxygen or ventilatory support, frequency of hyaline membrane disease, necrotizing enterocolitis, intraventricular hemorrhage, neonatal sepsis, or neonatal mortality. Our data suggest that tocolysis in patients with preterm premature rupture of membranes does not significantly improve perinatal outcome. Twit Text FOAVip Preterm premature rupture of membranes: aggressive tocolysis versus expectant management ????J Matern Fetal Med http://www.kidney.de/pget.php?&tw=1&pmid=9502662 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=9502662 #FOAvip English Wikipedia <ref>{{Cite pmid|9502662}}</ref> Preterm premature rupture of membranes: aggressive tocolysis versus expectant management #MMPMID9502662 How HY; Cook CR; Cook VD; Miles DE; Spinnato JA J Matern Fetal Med 1998[Jan]; 7 (1): 8-12 PMID9502662show ga The objective of our study is to determine whether aggressive tocolysis in patients with preterm premature rupture of membranes between 24 and 34 weeks gestation improves neonatal outcome. Patients with documented preterm premature rupture of membranes between 24 and 34 weeks gestation were prospectively randomized to group I, aggressive tocolysis with intravenous magnesium sulfate, or to group II, no tocolysis. The lecithin/sphingomyelin ratio was determined upon hospital admission and every 48-96 hours until delivery. Both groups received weekly steroids and antibiotics pending culture results and were promptly delivered when chorioamnionitis, fetal stress, or an Lecithin/sphingomyelin ratio of > or = 2.0 occurred. The study group involved 145 patients. No statistically significant differences between groups I (n = 78) and II (n = 67) were observed regarding demographic characteristics, gestational age at enrollment or at delivery, latency, development of clinical chorioamnionitis, birth weight, number of days in neonatal intensive care unit, days on oxygen or ventilatory support, frequency of hyaline membrane disease, necrotizing enterocolitis, intraventricular hemorrhage, neonatal sepsis, or neonatal mortality. Our data suggest that tocolysis in patients with preterm premature rupture of membranes does not significantly improve perinatal outcome. |*Tocolysis[MESH] |Adult[MESH] |Amniotic Fluid/chemistry[MESH] |Anti-Bacterial Agents/therapeutic use[MESH] |Chorioamnionitis/etiology/prevention & control[MESH] |Female[MESH] |Fetal Distress[MESH] |Fetal Membranes, Premature Rupture/complications/*therapy[MESH] |Gestational Age[MESH] |Humans[MESH] |Intensive Care, Neonatal[MESH] |Magnesium Sulfate/therapeutic use[MESH] |Phosphatidylcholines/analysis[MESH] |Pregnancy[MESH] |Prospective Studies[MESH] |Sphingomyelins/analysis[MESH]Preterm premature rupture of membranes: aggressive tocolysis versus ex(epmc).pdf DeepDyve Pubget Overpricing